International Patent: HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE

GENEVA, Sept. 24 -- VIGIL NEUROSCIENCE, INC. filed a patent application (US2026/020054) for “HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE”. With publication no. WO/2026/198852, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 498/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....